Breast Neoplasms: all 12,820 studies

Page 116 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.

• A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)CompletedNCT00600496Phase 1
• A Phase I/II Study of BGT226 in Adult Patients With Advanced Solid Malignancies Including Patients With Advanced Breast CancerCompletedNCT00600275Phase 1/2
• Assessment of the Efficacy of a Neoadjuvant Combination: "Chemotherapy-targeted Therapy" in Breast Cancer.CompletedNCT00600249Phase 2
• Partial Breast Radiation Therapy in Treating Women Undergoing Breast Conservation Therapy for Early-Stage Breast CancerCompletedNCT00599989Not applicable
• Effect of Soy Supplementation on Cellular Markers in Normal and Cancerous Breast Tissue: A Randomized Placebo Controlled StudyCompletedNCT00597532Not applicable
• An Access Delivery Model That Eliminates Barriers to Breast Cancer Care DeliveryCompletedNCT00597454Not applicable
• Korean Hereditary Breast Cancer StudyStatus unknownNCT00595348
• Quadrant High Dose Rate Intraoperative Radiation Therapy (IORT) for Early-Stage Breast Cancer: A Pilot StudyCompletedNCT00595062Not applicable
• Intensity Modulated Radiotherapy for Breast CancerCompletedNCT00594477Phase 1
• The Synergism Or Long Duration (SOLD) StudyCompletedNCT00593697Phase 3
• Strength Training for Older Breast Cancer SurvivorsCompletedNCT00591747Not applicable
• Phase III Comparison of Adjuvant Chemotherapy W/High-Dose Cyclophosphamide Plus Doxorubicin (AC) vs Sequential Doxorubicin Fol by Cyclophosphamide (A-C) in High Risk Breast Cancer Patients With 0-3 Positive Nodes (Intergroup, CALGB 9394)CompletedNCT00590785Phase 3
• Germline BRCA1 and BRCA2 Mutations in Jewish Women Affected by Breast CancerCompletedNCT00590109
• An All-Oral Combination of Capecitabine and Cyclophosphamide in Patients With Metastatic Breast Cancer (MBC)Status unknownNCT00589901Phase 2
• Menstrual Cycle Maintenance and Quality of Life: A Prospective StudyActive, not recruitingNCT00589654
• Paclitaxel, Doxorubicin, and Cyclophosphamide With Or Without Carboplatin in Treating Women With Locally Advanced Breast Cancer That Can Be Removed by SurgeryTerminatedNCT00589238Phase 2
• The Communication of Genetic Risk to Adolescent Daughters of Women With Breast CancerCompletedNCT00588705
• Quantification of Breast Sensation Following Postmastectomy Breast ReconstructionCompletedNCT00588419
• Collection of Tissue, Blood, and Cells to Be Used For Studying the Causes, Prevention, Diagnosis, and Treatment of Breast CancerActive, not recruitingNCT00588029
• Gene Expression Following Short Term Exposure to Neoadjuvant Endocrine Therapy in Invasive Breast CancerCompletedNCT00588003Phase 1
• Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast CancerCompletedNCT00587925Not applicable
• Peptide Profiles of Women Undergoing Breast BiopsyCompletedNCT00587821
• A Survey of Sleep Problems in Survivors of Breast CancerCompletedNCT00587340
• Efficacy and Safety of 500mg of FulvestrantActive, not recruitingNCT00585507Phase 2
• Intensive Combo Chemo With Autologous BM Rescue for Metastatic Breast CancerCompletedNCT00584766Phase 2
• Molecular Imaging of Breast Cancer With Breast PET/CTTerminatedNCT00584753Phase 1
• High Dose Chemo With Autologous BMT for Treatment of Metastatic Breast CancerCompletedNCT00584428Not applicable
• Mindfulness-based Stress Reduction in Breast Cancer RecoveryCompletedNCT00584142Not applicable
• Ultrasound Targeting for the Lumpectomy CavityCompletedNCT00583843
• Yoga to Reduce Cancer FatigueCompletedNCT00583739Phase 2
• Investigation of Changes in Bone Scan Imaging Before and After Intravenous Bisphosphonate Therapy for Osseous Metastases From Breast CancerCompletedNCT00582920Phase 1
• Adherence to Intensive Surveillance for Hereditary Breast CancerCompletedNCT00582803
• Investigating Mechanisms to Explain Age Associated Differences in Quality of Life Among Breast Cancer PatientsActive, not recruitingNCT00582478
• Genetic Studies in Breast CancerCompletedNCT00582322
• Cognitive Behavioral Therapy (CBT) and Physical Exercise for Climacteric Symptoms in Breast Cancer Patients Experiencing Treatment-Induced Menopause: a Multicenter Randomized TrialStatus unknownNCT00582244Phase 3
• Molecular Genetic Basis of Invasive Breast Cancer Risk Associated With Lobular Carcinoma in SituCompletedNCT00581750
• An Efficacy Study of Trabectedin in the Treatment of Participants With Specific Subtypes of Metastatic Breast CancerCompletedNCT00580112Phase 2
• Monitoring Response to Neoadjuvant Chemotherapy by the Use of Breast Proton MR SpectroscopyCompletedNCT00580086
• Newer Breast MRI Sequences for the Evaluation of Breast Cancer -FIESTA, Vibrant-DE and IDEAL: Feasibility EvaluationCompletedNCT00579800Not applicable
• Histologic Diagnoses of Incidentally Detected Lesions on MRIWithdrawnNCT00579735
• Germline Alterations of Tumor Susceptibility Genes in New York Cancer PatientsActive, not recruitingNCT00579514Not applicable
• Clinical Significance of Germline BRCA MutationsActive, not recruitingNCT00579488
• Use of Breast MRI for Local StagingWithdrawnNCT00579319
• Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial CancersActive, not recruitingNCT00579163
• Do Skin Markings Reflect the Location of the Surgical Cavity During Daily Radiotherapy Treatment?CompletedNCT00578747
• Breast MRI SpectroscopyCompletedNCT00577915Not applicable
• Veliparib and Irinotecan Hydrochloride in Treating Patients With Cancer That Is Metastatic or Cannot Be Removed by SurgeryCompletedNCT00576654Phase 1
• Hydralazine as Demethylating Agent in Breast CancerWithdrawnNCT00575978Phase 1/2
• Comparison of Sevoflurane and Isoflurane Anesthesia for Benign Breast Tumor ExcisionCompletedNCT00575354Phase 4
• Erlotinib and Everolimus in Treating Patients With Metastatic Breast CancerCompletedNCT00574366Phase 1
• Percutaneous Removal and Margin Ablation for Breast CancerCompletedNCT00574301Phase 1/2
• Multipeptide Vaccine for Advanced Breast CancerCompletedNCT00573495Phase 1
• Pilot Study of 18F Fluoropaclitaxel (FPAC)CompletedNCT00572598Early Phase 1
• Axillary Reverse MappingActive, not recruitingNCT00572481Phase 2
• Fatigue in Breast Cancer: A Behavioral Sleep InterventionCompletedNCT00572416Not applicable
• Effect of Tamoxifen or an Aromatase Inhibitor on Estrogen Metabolism in Women Treated for Newly Diagnosed Breast CancerCompletedNCT00569543
• Molecular Analysis of Breast CancerCompletedNCT00569049
• Bevacizumab, Everolimus (RAD001), and Lapatinib as Neoadjuvant Chemotherapy Regimes for Primary Breast CancerCompletedNCT00567554Phase 3
• The Effect of Grape Seed Extract on Estrogen Levels of Postmenopausal WomenCompletedNCT00566553Not applicable
• New Technique as an Additional Diagnostic Tool for Women Undergoing Neoadjuvant Therapy for Breast CancerCompletedNCT00566085Not applicable
• Healing Touch, Quality of Life, and Immunity During Breast Cancer TreatmentCompletedNCT00565305Not applicable
• Caelyx as Primary Treatment for Patients With Breast Cancer and a History of Heart Disease and/or Age Over 65 YearsCompletedNCT00563953Phase 2
• Non-interventional Study to Evaluate Arimidex in Postmenopausal Women With Advanced Breast CancerCompletedNCT00562458
• Maintenance Versus Observation After 6 Cycles of Gemcitabine Plus Paclitaxel in Pts With Advanced Breast CancerCompletedNCT00561119Phase 3
• Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine for Advanced Colorectal Cancer or Breast CancerStatus unknownNCT00559858Phase 3
• Effects of Fetal, Infant, and Early Childhood Exposures on Adult Cancer Risk in WomenCompletedNCT00559039
• A Phase 1-2, XIAP Antisense AEG35156 With Weekly Paclitaxel in Patients With Advanced Breast CancerTerminatedNCT00558545Phase 1/2
• Electronic Study for Anastrozole Pharmacovigilance EvaluationCompletedNCT00558168
• Local Surgery for Metastatic Breast CancerCompletedNCT00557986Not applicable
• Radiation Therapy During Surgery in Treating Older Women With Stage I Breast CancerCompletedNCT00556777Not applicable
• Meditation and Cognitive Function in Women With Breast CancerCompletedNCT00556218Not applicable
• ZK 230211 in Postmenopausal Woman With Metastatic Breast CancerCompletedNCT00555919Phase 2
• Patient's Anastrozole Compliance to Therapy ProgrammeTerminatedNCT00555867
• Safety and Efficacy of ALC in Breast Cancer in Subjects With FatigueTerminatedNCT00555841Phase 2
• A Pilot Study to Evaluate the Safety and Activities of EW02 in Reducing Neutropenia Caused by ChemotherapyStatus unknownNCT00555516Phase 1/2
• Registry of Mastectomy for Breast Cancer Risk ReductionCompletedNCT00555503
• Soy, Selenium and Breast Cancer RiskCompletedNCT00555386Not applicable
• Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver CancerStatus unknownNCT00553683Phase 1/2
• Validation Study Using the GeneSearch BLN Assay to Test Sentinel Lymph Nodes From Patients With Breast CancerCompletedNCT00551278
• Cognitive Changes Associated With Breast Cancer TreatmentCompletedNCT00550134
• Neoadjuvant Chemotherapy Including Sorafenib in Women With Previously Untreated Primary Breast CancerCompletedNCT00548899Phase 2
• The Active After Cancer Trial (AACT)Active, not recruitingNCT00548236Not applicable
• A Prospective,Open-label Study of Anastrozole in Post-menopausal Women With Hormone Sensitive Advanced Breast CancerCompletedNCT00544986Phase 4
• Lapatinib in Treating Patients With Advanced or Metastatic Breast Cancer That Overexpresses HER2CompletedNCT00544804Phase 1
• Docetaxel, Doxorubicin and Cyclophosphamide Versus Vinorelbine and Capecitabine in Patients Not Sufficiently / Sufficiently Responding as Preoperative Treatment of Locally Advanced or Operable Primary Breast CancerCompletedNCT00544765Phase 3
• Pre-operative Chemotherapy in Operable Breast Cancer, Phase III Study Comparing a Short Intensive Pre-operative Chemotherapy With the Same Therapy Initiated Shortly After Surgery(Peri-operatively)(POCOB)EORTC 10902)Status unknownNCT00544505Not applicable
• Family Quality of Life Among Families With a Member Who is a Cancer PatientCompletedNCT00544336
• Preoperative Epirubicin Paclitaxel Aranesp Study (PREPARE)CompletedNCT00544232Phase 3
• German Preoperative Adriamycin Docetaxel StudyCompletedNCT00543829Phase 2
• Survey in Post-menopausal Women Followed up After Treatment With Anastrozole as Adjuvant TherapyTerminatedNCT00542594
• Study of Anastrozole, Letrozole, or Exemestane With or Without Tamoxifen in Treating Postmenopausal Women With Hormone-Responsive Breast Cancer That Has Been Completely Removed By SurgeryStatus unknownNCT00541086Phase 3
• Monitoring the Response of Chemotherapy on Breast Cancer Tumor by Photon Migration SpectroscopyCompletedNCT00540852Not applicable
• BREAST-10: Three-weekly Versus Weekly First-line Chemotherapy for Metastatic or Locally Advanced Breast CancerCompletedNCT00540800Phase 3
• A Phase 2 Trial of Standard Chemotherapy, With or Without BSI-201, in Patients With Triple Negative Metastatic Breast CancerCompletedNCT00540358Phase 2
• "The Efficacy of 'Radioguided Occult Lesion Localization' (ROLL) Versus 'Wire-guided Localization' (WGL) in Breast Conserving Surgery for Non-palpable Breast Cancer: a Randomized Clinical Trial"CompletedNCT00539474Phase 3
• A Pilot Study to Evaluate Nipple-Areolar Complex (NAC) Sparing MastectomyCompletedNCT00539227
• Phase II Study of Neoadjuvant Chemotherapy With Doxorubicin Followed by Docetaxel-Cisplatin in Locally Advanced Breast CancerCompletedNCT00538525Not applicable
• Intensive Sequential Chemotherapy With Adriamycin Taxol and Cytoxan in the Treatment of Locally Advanced Breast CancerStatus unknownNCT00538395Not applicable
• Post Operative Adjuvant Chemotherapy Followed by Adjuvant Tamoxifen vs Nil for Patients With Operable Breast CancerStatus unknownNCT00538330Not applicable
• Predicting Response and Toxicity in Patients Receiving Paclitaxel and Avastin for Breast CancerTerminatedNCT00537173

← Breast Neoplasms overview